Back to funds
View filing
Spruce Street Capital LP
hedge fundUpdated 28 days agoManaged by Spruce Street Capital Lp • Latest filing Q2 2026
Portfolio value
$509.7M
Q2 2026
Filings
3
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 3 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $302.7M |
| Q1 2026 | $415.9M |
| Q2 2026 | $509.7M |
Top holdings
30 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | K KNSA KINIKSA PHARMACEUTICALS INTL | $58.7M | 918.1K | 11.52% | — |
| 2 | R RLAY RELAY THERAPEUTICS INC | $55.8M | 2.98M | 10.95% | — |
| 3 | L LBRX LB PHARMACEUTICALS INC | $44.7M | 1.38M | 8.76% | — |
| 4 | R RLMD RELMADA THERAPEUTICS INC | $44.2M | 6.39M | 8.68% | — |
| 5 | A ANRO ALTO NEUROSCIENCE INC | $35.7M | 1.35M | 7.01% | — |
| 6 | D DNTH DIANTHUS THERAPEUTICS INC | $34.6M | 354.8K | 6.79% | — |
| 7 | A ALKS ALKERMES PLC | $28.5M | 543.9K | 5.59% | — |
| 8 | S SVRA SAVARA INC | $21.3M | 3.45M | 4.17% | — |
| 9 | P PCVX VAXCYTE INC | $17.8M | 306.0K | 3.49% | — |
| 10 | E ELVN ENLIVEN THERAPEUTICS INC | $16.7M | 329.0K | 3.28% | — |
| 11 | E ENTA ENANTA PHARMACEUTICALS INC | $15.9M | 1.09M | 3.11% | — |
| 12 | ? N/A PERSPECTIVE THERAPEUTICS INC | $12.6M | 3.69M | 2.47% | — |
| 13 | I IFRX INFLARX NV | $12M | 5.35M | 2.35% | — |
| 14 | ? N/A SURROZEN INC | $11.2M | 432.0K | 2.20% | — |
| 15 | A ALMS ALUMIS INC | $11M | 392.6K | 2.17% | — |
| 16 | C CRNC CENTURY THERAPEUTICS INC | $9.9M | 4.06M | 1.95% | — |
| 17 | N NERV MINERVA NEUROSCIENCES INC | $9.2M | 1.66M | 1.80% | — |
| 18 | S SABSW SAB BIOTHERAPEUTICS INC | $8.6M | 2.20M | 1.68% | — |
| 19 | ? N/A AN2 THERAPEUTICS INC | $8M | 1.66M | 1.58% | — |
| 20 | E EQR ERASCA INC | $7.7M | 422.5K | 1.52% | — |